Variables | Intervention group | Differences between baseline and follow-up | Within group | Control group | Differences between baseline and follow-up | With in group | Differences in change over time between groups | ICC for clustering effect using LMM | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | Follow-up | Md (95 % CIs)a | p-valueb | α | Baseline | Follow-up | Md (95 % CIs)a | p-valueb | α | Md, (95 % CI)c, p-valued | ||
Empowerment | 4.0 (1.5;6.0) | 0.001 | 0.72 | -2.0 (-5.0;0.5) | 0.091 | 0.85 | 6.0 (3.0;9.0) 0.001 | 0,0768 | ||||
• Md (Q1-Q3) | 26.0 (21–29.3) | 30.0 (24–33) | 23.0 (20–31.8) | 20.5 (16–28.9) | ||||||||
• Min-max | 16–35 | 8–40 | 10–38 | 11–36 | ||||||||
Disempowerment | -1.3 (–2.0;0.0) | 0.018 | 0.65 | 1.0 (–0.5;2.5) | 0.115 | 0.85 | -2.0 (-4.0;-1.0) 0.006 | 0,0425 | ||||
• Md (Q1-Q3) | 3.0 (1–6) | 1.0 (0–4) | 2.0 (0–7) | 4.0 (1–7) | ||||||||
• Min-max | 0–9 | 0–18 | 0–13 | 0–16 | ||||||||
Total PCQ-P | 8.0 (4.5;11.4) | ≤0.001 | 0.86 | -8.5 (-13.6;-3.0) | 0.002 | 0.90 | 16.0 (9.7;23.0) ≤0.001 | 0,1164 | ||||
• Md (Q1-Q3) | 83.0 (75–93) | 94.0 (84.9–100) | 90.0 (78.7–96) | 77.0 (68.5–90) | ||||||||
• Min-max | 46–102 | 47–102 | 46–102 | 35–102 | ||||||||
Safety | 3.5 (1.5;5.5) | 0.001 | 0.84 | -3.4 (-6.0;-0.8) | 0.013 | 0.87 | 7.0 (3.8;10.0) ≤0.001 | 0,0568 | ||||
• Md (Q1-Q3) | 50.0 (47–57) | 56.0 (52–58) | 55.0 (49–59) | 50.0 (46.5–57.8) | ||||||||
• Min-max | 29–60 | 34–60 | 36–60 | 23–60 | ||||||||
Everydayness | 1.5 (0.0;3.0) | 0.009 | 0.81 | -2.0 (-4.0;0.0) | 0.028 | 0.76 | 4.0 (1.3;6.0) 0.001 | 0,0917 | ||||
• Md (Q1-Q3) | 20.0 (16–24) | 23.0 (19–24) | 21.0 (16–24) | 17.0 (13–21.5) | ||||||||
• Min-max | 7–24 | 5–24 | 4–24 | 4–24 | ||||||||
Hospitality | 3.0 (1.5;4.5) | ≤0.001 | 0.40 | -2.8 (-4.0;-1.5) | ≤0.001 | 0.49 | 6.0 (4.0;8.0) ≤0.001 | 0,1526 | ||||
• Md (Q1-Q3) | 13.0 (8–16) | 16.0 (14–18) | 15.0 (12–18) | 11.0 (8–14.5) | ||||||||
• Min-max | 8–18 | 8–18 | 6–18 | 6–18 | ||||||||
Quality of everyday activities | 9.7 (1.0;21.9) | 0.033 | 0.88 | -11.6 (-21.7;-3.4) | 0.012 | 0.93 | 22.1 (8.2;37.4) 0.002 | 0,2084 | ||||
• Md (Q1-Q3) | 36,7 (16.7–59.7) | 59.5 (26.2–77.6) | 46.6 (23.4–80.3) | 31.0 (20.2–60.2) | ||||||||
• Min-max | 14.3–89.8 | 14.3–98.0 | 14.3–100 | 14.3–98.0 | ||||||||
Sickness impact | 1.8 (-3.6;6.0) | 0.516 | 0.66 | -2.4 (-7.1;2.4) | 0.329 | 0.76 | 4.8 (-2.4;9.5) 0.235 | 0,0485 | ||||
• Md (Q1-Q3) | 69.0 (57.1–83.3) | 71.4 (59.5–85.7) | 81.0 (67.9–92.9) | 81.0 (67.9–88.5) | ||||||||
• Min-max | 33.3–100 | 16.7–97.6 | 40.5–100 | 38.1–100 | ||||||||
Physical symptoms | 0.0 (-3.1;3.1) | 0.911 | 0.43 | -1.0 (-3.1;1.0) | 0.333 | 0.64 | 2.0 (-2.0;6.1) 0.512 | 0,0285 | ||||
• Md (Q1-Q3) | 87.8 (81.6-93.9) | 91.8 (81.6-98) | 91.8 (83.7-99) | 91.8 (84.7-98) | ||||||||
• Min-max | 63.3–100 | 59.2–100 | 71.4–100 | 59.2–100 | ||||||||
Socio-economic situation | 0.0 (-5.4;4.8) | 0.962 | 0.79 | -4.2 (-8.9;0.0) | 0.047 | 0.79 | 3.6 (-3.6;10.7) 0.217 | 0,0134 | ||||
• Md (Q1-Q3) | 71.4 (57.1–82.1) | 71.4 (64.3–78.6) | 71.4 (64.3–82.1) | 71.4 (57.1–79.8) | ||||||||
• Min-max | 35.7–96.4 | 28.6–92.9 | 39.3–100 | 19–85.7 | ||||||||
Quality of life, item 34 | 0.0 (-1.0;0.5) | 0.320 | -0.5 (-1.0;0.0) | 0.044 | 0.0 (-1.0;1.0) 0.545 | |||||||
• Md (Q1-Q3) | 4.0 (4–5) | 4.0 (2–6) | 4.0 (3–6) | 4.0 (2.5–5) | ||||||||
• Min-max | 1–7 | 1–7 | 1–7 | 1–6 |